Study Selection
The review was conducted using a prospective protocol and reported per PRISMA guidelines. The study protocol was registered with PROSPERO (CRD42020175434), where the review protocol is available. Studies were selected for inclusion in two stages using Covidence © (2020). First, at least two authors (AAB, KAB, MS and DG) independently reviewed the titles and abstracts against inclusion criteria. Studies were excluded at this stage if they did not assess mode of delivery after a history of prior CS or were not carried out in SSA. Secondly, at least two independent reviewers (AAB, KAB, MS and DG) reviewed the full text of articles against inclusion criteria for final exclusion.